Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-020335
Filing Date
2021-04-23
Accepted
2021-04-23 16:05:29
Documents
6
Period of Report
2021-06-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A beam-def14a_20210609.htm DEF 14A 830833
2 GRAPHIC g3y3cjiepfha000005.jpg GRAPHIC 138723
3 GRAPHIC g3y3cjiepfha000001.jpg GRAPHIC 5352
4 GRAPHIC g3y3cjiepfha000004.jpg GRAPHIC 111858
5 GRAPHIC g3y3cjiepfha000003.jpg GRAPHIC 5352
6 GRAPHIC g3y3cjiepfha000002.jpg GRAPHIC 1460
  Complete submission text file 0001564590-21-020335.txt   1194432
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Filer) CIK: 0001745999 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39208 | Film No.: 21849731
SIC: 2836 Biological Products, (No Diagnostic Substances)